Cambridge Investment Research Advisors Inc. Boosts Position in Nutanix Inc (NTNX)

Share on StockTwits

Cambridge Investment Research Advisors Inc. boosted its holdings in Nutanix Inc (NASDAQ:NTNX) by 22.0% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,698 shares of the technology company’s stock after acquiring an additional 1,570 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in Nutanix were worth $449,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Aperio Group LLC purchased a new stake in shares of Nutanix in the 1st quarter worth $205,000. Cornerstone Wealth Management LLC purchased a new stake in Nutanix in the 2nd quarter worth $260,000. People s United Financial Inc. purchased a new stake in Nutanix in the 2nd quarter worth $271,000. Public Employees Retirement Association of Colorado increased its stake in Nutanix by 247.1% in the 2nd quarter. Public Employees Retirement Association of Colorado now owns 5,546 shares of the technology company’s stock worth $286,000 after buying an additional 3,948 shares in the last quarter. Finally, Financial Enhancement Group LLC purchased a new stake in Nutanix in the 2nd quarter worth $321,000. 49.44% of the stock is currently owned by institutional investors and hedge funds.

NASDAQ NTNX traded up $2.87 during trading on Friday, hitting $41.46. The stock had a trading volume of 3,218,893 shares, compared to its average volume of 3,653,003. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.76 and a quick ratio of 2.76. Nutanix Inc has a one year low of $25.50 and a one year high of $64.87. The company has a market cap of $7.39 billion, a P/E ratio of -24.53 and a beta of 0.69.

Nutanix (NASDAQ:NTNX) last posted its quarterly earnings results on Thursday, August 30th. The technology company reported ($0.11) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.48) by $0.37. Nutanix had a negative net margin of 25.72% and a negative return on equity of 92.86%. The firm had revenue of $303.75 million during the quarter, compared to the consensus estimate of $298.30 million. As a group, equities research analysts expect that Nutanix Inc will post -2.18 EPS for the current year.

In related news, EVP David Sangster sold 7,916 shares of Nutanix stock in a transaction that occurred on Tuesday, September 4th. The shares were sold at an average price of $55.75, for a total transaction of $441,317.00. Following the transaction, the executive vice president now directly owns 7,916 shares of the company’s stock, valued at $441,317. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John Mcadam sold 15,000 shares of Nutanix stock in a transaction on Monday, September 10th. The stock was sold at an average price of $51.46, for a total transaction of $771,900.00. Following the completion of the transaction, the director now directly owns 84,648 shares in the company, valued at $4,355,986.08. The disclosure for this sale can be found here. Insiders have sold 39,204 shares of company stock valued at $1,974,724 in the last ninety days. Insiders own 19.81% of the company’s stock.

A number of equities research analysts have issued reports on NTNX shares. Susquehanna Bancshares reiterated a “negative” rating and issued a $33.00 price target (down previously from $55.00) on shares of Nutanix in a research note on Monday, September 24th. UBS Group lowered Nutanix to a “neutral” rating in a research report on Monday, September 24th. Zacks Investment Research lowered Nutanix from a “hold” rating to a “sell” rating in a research report on Friday, August 24th. JPMorgan Chase & Co. upgraded Nutanix from an “underweight” rating to a “neutral” rating and raised their price objective for the company from $39.00 to $54.00 in a research report on Thursday, August 30th. Finally, Needham & Company LLC raised their price objective on Nutanix from $65.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, August 31st. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and seventeen have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $57.55.

Nutanix Company Profile

Nutanix, Inc, together with its subsidiaries, develops and provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. Its solution addresses a range of workloads, including enterprise applications, databases, virtual desktop infrastructure, unified communications, and big data analytics.

Read More: Book Value Per Share in Stock Trading

Institutional Ownership by Quarter for Nutanix (NASDAQ:NTNX)

Receive News & Ratings for Nutanix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutanix and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.